CEFOTETAN, 95%, 250mg

Éster etílico del ácido cloroacético, >=98%, para síntesis, 1 L, envase de vidrio

tert-Butyl (3-(trifluoromethyl)phenyl)carbamate, 95.0%, 5g

2-hydroxy-5-(morpholin-4-ylsulfonyl)benzoic acid, 95.0%, 5g

5-Chloromethyl-3-phenyl-[1,2,4]oxadiazole, 97.0%, 2.5g

4-[2-(4-Fluoro-phenyl)-ethyl]-piperidine hydrochloride, 1g

(3-methylphenyl)[4-(2-methylphenyl)piperazin-1-yl]acetic acid, 250mg

2-(Bromomethyl)-6-fluoropyridine, 95.0%, 10g

6-BOC-1,6-Diazaspiro[3.5]nonane, 97.0%, 1g

2-Ethylnaphthalene, 99.0%, 5g

(1R,3R,E)-5-(2-((1R,3aS,7aR,E)-7a-Methyl-1-((R)-6-methylheptan-2-yl)octahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, 98%, 5mg

Benzyl2-(4-methoxycarbonylphenyl)-4-oxo-piperidine-1-carboxylate, 98%, 1g

8-(4-Chloro-2-methoxyphenyl)-8-oxooctanoic acid, 97.0%, 1g